Xenon Contrast Agent

Xenon contrast agents are imaging substances that use the noble gas xenon to improve the visibility of anatomical structures, air spaces, or physiological processes. In biomedical engineering, hyperpolarized xenon-129 is commonly produced by spin-exchange optical pumping, inhaled by a subject, and detected with magnetic resonance imaging as it moves through the lungs and dissolves into surrounding tissues; xenon’s magnetic signal reveals regional ventilation and gas exchange. These agents support noninvasive assessment of pulmonary function, including abnormalities that conventional structural imaging may miss. Their tunable behavior and ability to report both gas distribution and tissue interaction also make them valuable for developing advanced diagnostic imaging systems.

Xenon Contrast Agent - Related Videos

Research

JoVE Journal - Chemistry

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

0 Views •

Cited by 5 •

2016

This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.

Hyperpolarized Xenon for NMR and MRI Applications

0 Views •

Cited by 28 •

2012

The production of hyperpolarized xenon by means of spin exchange optical pumping (SEOP) is described. This method yields a ~10000-fold enhancement of the nuclear spin polarization of Xe-129 and has applications in nuclear magnetic resonance spectroscopy and imaging. Examples of gas phase and solution state experiments are given.

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

0 Views •

Cited by 3 •

2013

To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

0 Views •

Cited by 2 •

2013

We demonstrate how to perform macrophage MR imaging using ultrasmall superparamagnetic contrast agent (USPIO) in septic arthritis, allowing an initial and longitudinal in vivo non-invasive evaluation of macrophages infiltration and an assessment of therapy efficacy.

Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging

0 Views •

Cited by 9 •

2011

We demonstrate the metalation, purification, and characterization of lanthanide complexes. The complexes described here can be conjugated to macromolecules to enable tracking of these molecules using magnetic resonance imaging.

View All Results

FAQs

Related Topics